Who Paid My Doc
Axxent Surface Controller
Device Oncology
PDI 00858012005526
General payments
$463,708
Research payments
$468,060
Through program year 2023, $463,708 in general payments and $468,060 in research payments were reported against Axxent Surface Controller (Oncology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2023 | General | $12,917 | 30 |
| 2023 | Research | $158,458 | 43 |
| 2022 | General | $229,696 | 155 |
| 2021 | General | $221,096 | 126 |
| 2021 | Research | $309,602 | 51 |
Breakdown
The top 5 of 20 recipients; each share is of general payments naming this product in 2023.
The top 5 of 6 specialties; each share is of general payments naming this product to practitioners with a specialty in 2023. Each practitioner is counted under their primary specialty.
The top 5 of 10 states; each share is of general payments naming this product in 2023 where a state was reported.
Records
311 general · 94 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.